Announcements
11 articles
Prevision study with PI Dr Manar Khashram
- 3 May 2023
Our Clinical Trials NZ vascular team has been conducting Prevision study with PI Dr Manar Khashram.
A pilot randomised controlled trial of oral doxycycline after endoscopic sinus surgery and its effects on the sinonasal microbiome.
- 17 January 2023
Challis JM, Baptista MS, Ragupathy R, Lee CK, Wood AJ. Rhinology Online. 2022; 5: 49-61
2023 ARCS Annual Conference (6 – 8 June 2023)
- 10 November 2022
The 2023 ARCS Annual Conference (6 – 8 June 2023) will be held at the International Convention Centre (ICC), Darling Harbour, Sydney.
9th VERVE Symposium in Sydney in December
- 10 November 2022
Welcome to the NEXT LEVEL in VASCULAR EDUCATION
Clinical Feasibility Study for Endovenous Deep Vein Valve Formation for Chronic Venous Insufficiency
- 18 June 2019
Initial Results. Mr. Thodur Vasudevan, Clinical Trials NZ
SABER™ Bupivacaine, a novel extended-release formulation of bupivacaine for postoperative pain control...
- 15 October 2014
demonstrates dose-response, safety and no impact on surgical wound healing.
SABER™ Bupivacaine Reduces Postoperative Pain Intensity and Opioid Use for 72 Hours in Soft-Tissue and Bony Surgeries
- 15 October 2014
Poster presentation American Society of Anaesthesiologists, October 15 2014
Intranasal Ketorolac (ROX-888) for Postoperative Pain: A Phase 3, Double-Blind, Randomized Study
- 8 May 2008
Presented at the 2008 Society for Ambulatory Anesthesia Annual Meeting
Post-Operative Pain Control with Extended-Release Bupivacaine Formulation. Clinical Trial Results in Inguinal Hernia Repair
- 15 March 2008
American Hernia Society, March 15, 2008